Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, "Edmond and Lily Safra" Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel; Division of Haematology and Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel; Sheba Cancer Research Center, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, "Edmond and Lily Safra" Children's Hospital, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Clin Immunol. 2020 May;214:108376. doi: 10.1016/j.clim.2020.108376. Epub 2020 Mar 3.
Primary immunodeficiencies (PIDs) are a heterogeneous group of monogenic inborn errors of immunity. The genetic causes of these diseases can be identified using whole exome sequencing (WES). Here, DNA samples from 106 patients with a clinical suspicion of PID were subjected to WES in order to test the diagnostic yield of this test in a highly consanguineous community. A likely genetic diagnosis was achieved in 70% of patients. Several factors were considered to possibly influence the diagnostic rate of WES among our cohort including early age, presence of consanguinity, family history suggestive of PID, the number of family members who underwent WES and the clinical phenotype of the patient. The highest diagnostic rate was in patients with combined immunodeficiency or with a syndrome. Notably, WES findings altered the clinical management in 39% (41/106) of patients in our cohort. Our findings support the use of WES as an important diagnostic tool in patients with suspected PID, especially in highly consanguineous communities.
原发性免疫缺陷病(PIDs)是一组异质性的单基因遗传性免疫缺陷病。这些疾病的遗传原因可以通过外显子组测序(WES)来确定。在这里,对 106 名有 PID 临床疑似症状的患者的 DNA 样本进行了 WES 检测,以测试该检测在高度近亲结婚社区中的诊断效果。在 70%的患者中实现了可能的遗传诊断。考虑了几个因素,这些因素可能会影响我们队列中 WES 的诊断率,包括年龄小、有近亲结婚、有 PID 家族史、接受 WES 的家庭成员数量以及患者的临床表型。在联合免疫缺陷或综合征患者中,诊断率最高。值得注意的是,WES 检测结果改变了我们队列中 39%(41/106)患者的临床管理。我们的研究结果支持将 WES 作为疑似 PID 患者的重要诊断工具,尤其是在高度近亲结婚的社区中。